Matthew M Hsieh MD

Hematologic Oncology

Clinical Research at NIH

9000 Rockville PikeBldg 10Bethesda, MD 20892
Phone+1 301-402-7687
Fax+1 301-480-8975

Dr. Hsieh is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hsieh's full profile Already have an account?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 1998 - 2001
University of Vermont College of MedicineClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2001 - 2028
American Board of Internal Medicine Hematology

Clinical Trials

Natural History Study for BEN Start of enrollment: 2003 Jun 03
COMPLETED
Screening for Subjects to Participate in Studies of Blood Disorders Start of enrollment: 2008 Jul 03
COMPLETED
Decitabine for High-Risk Sickle Cell Disease
COMPLETED
PHASE2

Publications & Presentations

PubMed

Hematopoietic Stem Cell Transplant and Brain Volume Changes in Adults With Sickle Cell Disease.
Kyle C Kern, Zaina Inam, Matthew M Hsieh, John F Tisdale, Courtney D Fitzhugh
Neurology. 2026-06-09
2 citations
Comparative analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model.
Henna Butt, Shruti Sathish, Evan London, Anh Le, Quan Li
Blood Advances. 2026-01-27
Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell disease.
Emily Limerick, Matthew Hsieh, Jackie Queen, Mary Lacy Grecco, Julia Varga
Plos One. 2026-01-01

Abstracts/Posters

CRISPR-Cas9 Genome Editing of _-Globin Promoters in Human Hematopoietic Stem Cells to Induce Erythrocyte Fetal Hemoglobin for Treatment of _-Hemoglobinopathies
Matthew Hsieh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor
Matthew Hsieh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019